Back to Search Start Over

Lipid and Corticosteroid Biomarkers Under the Influence of Bisphosphonates.

Authors :
Tou K
Cawley A
Noble G
Loy J
Bishop D
Keledjian J
Sornalingam K
Richards S
Fu S
Source :
Drug testing and analysis [Drug Test Anal] 2024 Oct 15. Date of Electronic Publication: 2024 Oct 15.
Publication Year :
2024
Publisher :
Ahead of Print

Abstract

Detecting the use of bisphosphonates (BPs) in equine athletes is of interest to regulators and laboratories due to the threat to welfare issues for the potential to provide analgesic effects and manipulating bone structure. The detection of BPs in biological matrices is challenging due to erratic biological elimination and inconsistent analytical recoveries. Therefore, complementary approaches are needed to provide evidence of their misuse in racehorses. BPs have two sub-classes: nitrogenous and non-nitrogenous. This study investigated plasma elimination following administration of one example from each sub-class, together with changes in endogenous eicosanoid and corticosteroids. Zoledronic acid (ZA) and tiludronic acid (TA) were administered by IV infusion to 8 thoroughbred horses with an 11-month washout period between each administration. Sample preparation for quantification of BPs by liquid chromatography-tandem mass spectrometry (LC-MS/MS) utilised a two-step solid phase extraction (SPE) consisting of polymeric reversed-phase followed by weak anion exchange prior to derivatisation using trimethyl orthoacetate. Endogenous biomarkers were analysed after protein precipitation and SPE with polymeric reversed-phase prior to liquid chromatography-high resolution mass spectrometry (LC-HRMS) using data independent acquisition. The LC-MS/MS analysis showed ZA was undetectable after 8 h post-administration while TA was detected up to the final collection point of 28 days post-administration. The LC-HRMS analysis utilised targeted (i.e., prior inclusion list of compounds) approaches to monitor level changes of eicosanoid and corticosteroid biomarkers. Putative biomarkers were identified and now subject to validation for translation into routine sample analysis for improved retrospectivity to detecting BP misuse in equine plasma.<br /> (© 2024 The Author(s). Drug Testing and Analysis published by John Wiley & Sons Ltd.)

Details

Language :
English
ISSN :
1942-7611
Database :
MEDLINE
Journal :
Drug testing and analysis
Publication Type :
Academic Journal
Accession number :
39407358
Full Text :
https://doi.org/10.1002/dta.3811